{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:40Z","timestamp":1786984300333,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.amjms.2017.11.008","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T21:30:10Z","timestamp":1511299810000},"page":"247-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease"],"prefix":"10.1016","volume":"355","author":[{"given":"B. Tate","family":"Cutshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Benjamin T.","family":"Duhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannath","family":"Saikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Samarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Q.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2017.11.008_bib2","series-title":"2015 USRDS annual data report: epidemiology of kidney disease in the United States","year":"2015"},{"issue":"3","key":"10.1016\/j.amjms.2017.11.008_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1681\/ASN.2014030253","article-title":"ESRD and death after heart failure in CKD","volume":"26","author":"Sud","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.amjms.2017.11.008_bib4","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2017.11.008_bib5","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"23","key":"10.1016\/j.amjms.2017.11.008_bib6","first-page":"1429","article-title":"The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2017.11.008_bib7","first-page":"293","article-title":"The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.amjms.2017.11.008_bib8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.11.008_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2017.11.008_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjms.2017.11.008_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ahj.2011.05.004","article-title":"Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis","volume":"162","author":"Chang","year":"2011","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.amjms.2017.11.008_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2017.11.008_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjms.2017.11.008_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/ndt\/gfl752","article-title":"No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients","volume":"22","author":"Han","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.amjms.2017.11.008_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jchf.2016.03.002","article-title":"Trends in the use of guideline-directed therapies among dialysis patients hospitalized with systolic heart failure: findings from the American Heart Association Get With The Guidelines-Heart Failure Program","volume":"4","author":"Pandey","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjms.2017.11.008_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1681\/ASN.2014040324","article-title":"\u00df-blocker dialyzability and mortality in older patients receiving hemodialysis","volume":"26","author":"Weir","year":"2014","journal-title":"J Am Soc Nephrol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917306109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917306109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T18:56:40Z","timestamp":1535223400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917306109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0002962917306109"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.11.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}